Baidu
map
NEPHRON 润色咨询

NEPHRON

出版年份:暂无数据 年文章数:1712 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=806236, encodeId=c3d580623682, content=请问大家,投了1个月了,状态in review是审稿人再审吗?这是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Wed Aug 05 08:51:56 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542343, encodeId=244754234378, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511568, encodeId=6592511568f0, content=Nephron. 2015;129(3):155-63. <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd41308221, createdName=imp_znnancy, createdTime=Thu Apr 30 20:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=)]
    2020-08-05 如梅

    请问大家,投了1个月了,状态in review是审稿人再审吗?这是送外审了吗

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=806236, encodeId=c3d580623682, content=请问大家,投了1个月了,状态in review是审稿人再审吗?这是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Wed Aug 05 08:51:56 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542343, encodeId=244754234378, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511568, encodeId=6592511568f0, content=Nephron. 2015;129(3):155-63. <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd41308221, createdName=imp_znnancy, createdTime=Thu Apr 30 20:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=)]
    2017-07-14 qiqi

    从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=806236, encodeId=c3d580623682, content=请问大家,投了1个月了,状态in review是审稿人再审吗?这是送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/jO2jcU8qMUGAf0w3AOSCMq7qGUbJOBuZFdrWIEXIC9ohbXFnHSFsB5cACaIIry0yx1XKmoCWZQ9ggKhaib2bhzA/132, createdBy=29b65327550, createdName=如梅, createdTime=Wed Aug 05 08:51:56 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542343, encodeId=244754234378, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511568, encodeId=6592511568f0, content=Nephron. 2015;129(3):155-63. <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9cd41308221, createdName=imp_znnancy, createdTime=Thu Apr 30 20:04:00 CST 2015, time=2015-04-30, status=1, ipAttribution=)]
    2015-04-30 imp_znnancy

    Nephron. 2015;129(3):155-63.

    0

共9条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map